Medtech M&A has remained strong through the first half of 2026. This and more in this week's life sciences update. Biotech ...
Next week’s economic releases and policy decisions will affect asset pricing and expectations for interest rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results